DEBM_CompanyBanner_InnovationFund_LG

Debiopharm Innovation Fund S.A.


investing in
future
patient
care

Business

Discover our Portfolio

10 active investments

Discover
Latest news
April 5, 2018

Kaiku Health raises €4.4 million series A financing to accelerate its digital therapeutics pipeline led by Debiopharm and Tesi

Read more
May 9, 2017

BC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development

Read more
See all news
Agenda
Let's meet

BIO Europe 2018

November 5 - 7, 2018 Copenhagen, Danmark Discover
See all events

Investing in future patient care

We invest in young innovative companies in the following areas

Smart data
pilot or early commercial stage
Therapeutics
discovery or early development
Diagnostics
development stage

At a glance

Our mission

Debiopharm Innovation Fund’s objective is to make strategic investments in innovative companies with technologies and business models that change the way we develop drugs and treat patients.

We bring value to our portfolio companies through our knowledge in medicine, pharmaceutical development, regulatory/reimbursement aspects, management and expertise in bringing products to market. We drive our portfolio investments to successful exits.

 

Our objective

Make new investments in companies developing innovative therapeutics, diagnostics, and smart data solutions with a spirit of partnership. Our goals are:

  • Long term value creation
  • Minority participation
  • Advising and helping with technical and business operations
  • Active in the Board of Directors

Our investment criteria

  • Experienced management team
  • Innovative technology
  • Fit with Debiopharm Group’s interests
  • Strong execution plan

Our achievements (as Debiopharm Diagnostics)

  • Over USD 95 million invested since 2008
  • Cumulative equity raised by all companies: USD 500 million
  • Debiopharm Diagnostics led 10 out of the 14 last investment rounds
  • Progress to date: 4 companies with commercial products, one M&A and one IPO.
CEO of Debiopharm Innovation Fund S.A.
Management

Discover the members who guide and bring long-term vision to the company

Discover
Contact us

Would like to partner with us? Got a question or a comment? Get in touch!

Discover